Back
C3.ai, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Sell
50
AI
C3.ai, Inc.
Last Price:
$15.28
Seasonality Move:
-2.75%
Sell
49
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$36.24
Seasonality Move:
6.21%
Sell
50
C3.ai, Inc. (AI)
is a Sell
Is C3.ai, Inc. a Buy, Sell or Hold?
-
The current C3.ai, Inc. [AI] share price is $15.27. The Score for AI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
AI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.20. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AI Stock Price Chart
What is C3.ai, Inc.'s stock price today?
-
The C3.ai, Inc. share price today is $15.27The current trend is relatively stagnant and AI is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
AI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 49.9 | Sell |
| Chaikin Money Flow: | -2455420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.72 - 15.54) | Buy |
| Bollinger Bands (100): | (14.71 - 20.39) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 61.03 | Buy |
| Chaikin Money Flow: | -408394 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.49 | Sell |
| 20-day SMA: | 14.5 | Buy |
| 50-day SMA: | 16.32 | Sell |
| 200-day SMA: | 20.46 | Sell |
| 8-day EMA: | 15.38 | Sell |
| 20-day EMA: | 15.15 | Buy |
| 50-day EMA: | 16 | Sell |
| 200-day EMA: | 20.35 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.97 | Buy |
| 20-day SMA: | 34.2 | Buy |
| 50-day SMA: | 33.3 | Buy |
| 200-day SMA: | 33.78 | Buy |
| 8-day EMA: | 35.77 | Buy |
| 20-day EMA: | 34.71 | Buy |
| 50-day EMA: | 33.43 | Buy |
| 200-day EMA: | 34.79 | Buy |
C3.ai, Inc. Earnings Growth & AI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.02 per share, an increase this year of $0.22 per share, and a decrease next year of $0.75 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
C3.ai, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||